Drugmaker Johnson & Johnson said it would buy back up to $10 billion of common stock over time.
The company said on Tuesday it had about 2.77 billion shares of common stock outstanding as of Sept. 27.
Continue Reading Below
J&J is expected to report its third-quarter results on Tuesday before the markets open.
(Reporting by Vidya L Nathan in Bengaluru; Editing by Kirti Pandey)